Showing results (1261-1270 of 1,820) with videos related to
Sort By:
Pageof 182
ACS Applied Materials & Interfaces|March 16, 2018
Obtaining Thickness-Limited Electrospray Deposition for 3D CoatingLin Lei, Dylan A Kovacevich, Michael P Nitzsche, et al.Psychiatry Research|July 19, 2014
The effects of carbamazepine on prefrontal activation in manic youth with bipolar disorderMarguerite Reid Schneider, Christina C Klein, Wade Weber, et al.Psychological Medicine|April 5, 2023
Antiviral treatment in schizophrenia: a randomized pilot PET study on the effects of valaciclovir on neuroinflammationIris Jonker, Janine Doorduin, Henderikus Knegtering, et al.Parkinsonism & Related Disorders|February 9, 2017
Personality and addictive behaviours in early Parkinson's disease and REM sleep behaviour disorderFahd Baig, Michael A Lawton, Michal Rolinski, et al.The Journal of Pharmacology and Experimental Therapeutics|September 1, 1996
Recirculatory pharmacokinetic models of markers of blood, extracellular fluid and total body water administered concomitantlyT C Krejcie, T K Henthorn, C U Niemann, et al.Neurology|August 15, 2002
Dopamine transmission in DYT1 dystonia: a biochemical and autoradiographical studySarah J Augood, Z Hollingsworth, D S Albers, et al.Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|August 28, 2002
Hemorrhagic shockMarie-Jocelyne Martel, Katherine Jane MacKinnon, Marc-Yvon Arsenault, et al.Neuroimage. Clinical|January 25, 2017
Longitudinal changes of cortical microstructure in Parkinson's disease assessed with T1 relaxometryLucas Nürnberger, René-Maxime Gracien, Pavel Hok, et al.International Journal of Cancer|February 10, 1998
Inactivation of p53 in normal human cells increases G2/M arrest and sensitivity to DNA-damaging agentsJ Céraline, G Deplanque, B Duclos, et al.Journal of Biological Rhythms|May 4, 2017
Daily Rhythm in Plasma N-acetyltryptaminePeter S Backlund, Henryk F Urbanski, Mark A Doll, et al.Pageof 182